computationally designed antigen targets range of coronaviruses
In a recent study published in Nature Biomedical Engineering, researchers used an interdisciplinary approach incorporating phylogenetics, 3D protein modeling, and ...
In a recent study published in Nature Biomedical Engineering, researchers used an interdisciplinary approach incorporating phylogenetics, 3D protein modeling, and ...
In a recent preprint posted to the bioRxiv* server, researchers characterized two novel XBB variants, EG.5.1 and XBB.2.3, with the former ...
Severe COVID-19 may cause long-lasting alterations to the innate immune system, the first line of defense against pathogens, according to ...
Unexpected new insights into how COVID-19 infects cells may help explain why coronaviruses are so good at jumping from species ...
Recently, scientists reviewed the available literature to better understand vitamin D's immunomodulatory and antiviral function. The study explores how vitamin ...
In a recent study published in The Lancet Public Health, researchers performed a meta-analysis on the utility of syphilis self-testing ...
Millions of deaths and ongoing illnesses caused by the COVID-19 pandemic have prompted scientists to seek new ways of understanding ...
The range of COVID-19 symptoms varies-; some feel a mild cold, others are hospitalized, while others perish. Many studies have ...
In a recent study published in the Nature Aging Journal, researchers investigated the role of senescent cells in the context ...
A recent study published in the BMJ investigated the associations between coronavirus disease 2019 (COVID-19) vaccination or non-vaccination and adverse ...
Forget walking 10,000 steps a day. Taking at least 50 steps climbing stairs each day could significantly slash your risk...
Read moreExamples of mismatched materials of varying thermal dynamics, cured at various temperatures, causing warpage, cracking and potential breakage. The results...
Read moreA new study shows that delivery of gene therapy to correct the gene mutations that cause CLN2 disease, or Batten...
Read moreAmbu CEO Britt Meelby Jensen Ambu’s CEO seeks to “Zoom In” on what the Danish company has done best. More...
Read more© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.